Projects

To study the Utilisation of hemodialysis and peritoneal dialysis in children with end stage kidney disease

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - 2025

Project Lead

Dr. Nivedita Kamath

Authors

Dr. Nivedita Kamath, Dr. Anil Vasudevan

Project Status

completed